CALCA and irritable bowel syndrome: According to the authors, these results suggest that peripheral CGRP plays and important role in visceral nociception and organ cross-sensitization, supporting the notion that CGRP could be a therapeutic target for visceral pain in patients with IBS and/or BPS/IC.